These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

430 related items for PubMed ID: 21061682

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in the prediction of outcome of patients with multiple myeloma: a comparative study.
    Fonti R, Pace L, Cerchione C, Catalano L, Salvatore B, De Luca S, Pane F, Salvatore M, Del Vecchio S.
    Clin Nucl Med; 2015 Apr; 40(4):303-8. PubMed ID: 25608167
    [Abstract] [Full Text] [Related]

  • 4. Analysis of thymidine kinase serum levels by novel method DiviTum in multiple myeloma and monoclonal gammopathy of undetermined significance - comparison with imaging methods 99mTc-MIBI scintigraphy and 18F-FDG PET/CT.
    Bacovsky J, Myslivecek M, Minarik J, Scudla V, Pika T, Zapletalova J, Petrova P, Bartkova M, Adam T, Gronowitz SJ.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Mar; 159(1):135-8. PubMed ID: 24572488
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of whole-body 18F-FDG PET, 99mTc-MIBI SPET, and post-therapeutic 131I-Na scintigraphy in the detection of metastatic thyroid cancer.
    Iwata M, Kasagi K, Misaki T, Matsumoto K, Iida Y, Ishimori T, Nakamoto Y, Higashi T, Saga T, Konishi J.
    Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):491-8. PubMed ID: 14666387
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prospective Comparison of 99mTc-MDP Scintigraphy, Combined 18F-NaF and 18F-FDG PET/CT, and Whole-Body MRI in Patients with Breast and Prostate Cancer.
    Minamimoto R, Loening A, Jamali M, Barkhodari A, Mosci C, Jackson T, Obara P, Taviani V, Gambhir SS, Vasanawala S, Iagaru A.
    J Nucl Med; 2015 Dec; 56(12):1862-8. PubMed ID: 26405167
    [Abstract] [Full Text] [Related]

  • 9. Diagnostic relevance of 18F-FDG PET/CT in newly diagnosed patients with monoclonal gammopathy of undetermined significance (MGUS): Single-center experience.
    Sandecka V, Adam Z, Krejci M, Stork M, Rehak Z, Koukalova R, Sevcikova S, Brozova L, Kral Z, Mayer J, Pour L.
    Neoplasma; 2020 Jul; 67(4):939-945. PubMed ID: 32567936
    [Abstract] [Full Text] [Related]

  • 10. Thyroid nodules with indeterminate cytology: prospective comparison between 18F-FDG-PET/CT, multiparametric neck ultrasonography, 99mTc-MIBI scintigraphy and histology.
    Piccardo A, Puntoni M, Treglia G, Foppiani L, Bertagna F, Paparo F, Massollo M, Dib B, Paone G, Arlandini A, Catrambone U, Casazza S, Pastorino A, Cabria M, Giovanella L.
    Eur J Endocrinol; 2016 May; 174(5):693-703. PubMed ID: 26966173
    [Abstract] [Full Text] [Related]

  • 11. [The value of fluorodeoxyglucose positron emission tomography in multiple myeloma].
    Adam Z, Bolcák K, Stanícek J, Pour L, Hájek R, Krejcí M, Prásek J, Neubauer J, Mareschova Y, Vorlícek J.
    Vnitr Lek; 2006 Mar; 52(3):207-14. PubMed ID: 16722151
    [Abstract] [Full Text] [Related]

  • 12. Multiple myeloma: predictive value of Tc-99m MIBI scintigraphy and MRI in its diagnosis and therapy.
    Myslivecek M, Nekula J, Bacovsky J, Scudla V, Koranda P, Kaminek M.
    Nucl Med Rev Cent East Eur; 2008 Mar; 11(1):12-6. PubMed ID: 19173182
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. ¹⁸F-FDG PET/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders.
    Dammacco F, Rubini G, Ferrari C, Vacca A, Racanelli V.
    Clin Exp Med; 2015 Feb; 15(1):1-18. PubMed ID: 25218739
    [Abstract] [Full Text] [Related]

  • 15. Diagnostic relevance of 2-[18 F]-FDG PET/CT in patients recently diagnosed with monoclonal gammopathy of undetermined significance.
    Rudolphi-Solero T, Triviño-Ibáñez EM, González-Jiménez AD, Ramos-Font C, Ríos-Tamayo R, Rebollo-Aguirre AC, Sánchez-Sánchez R.
    Hematol Oncol; 2023 Aug; 41(3):434-441. PubMed ID: 36222822
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of Tc-99m sestamibi and F-18 FDG-PET in the assessment of multiple myeloma.
    Hung GU, Tsai CC, Tsai SC, Lin WY.
    Anticancer Res; 2005 Aug; 25(6C):4737-41. PubMed ID: 16334169
    [Abstract] [Full Text] [Related]

  • 18. Pilot prospective evaluation of 99mTc-MDP scintigraphy, 18F NaF PET/CT, 18F FDG PET/CT and whole-body MRI for detection of skeletal metastases.
    Iagaru A, Young P, Mittra E, Dick DW, Herfkens R, Gambhir SS.
    Clin Nucl Med; 2013 Jul; 38(7):e290-6. PubMed ID: 23455520
    [Abstract] [Full Text] [Related]

  • 19. Whole-body (18)F-FDG PET identifies high-risk myeloma.
    Durie BG, Waxman AD, D'Agnolo A, Williams CM.
    J Nucl Med; 2002 Nov; 43(11):1457-63. PubMed ID: 12411548
    [Abstract] [Full Text] [Related]

  • 20. Comparison of ⁶⁸Ga-DOTATATE PET-CT, ¹⁸F-FDG PET-CT and 99mTc-(V)DMSA scintigraphy in the detection of recurrent or metastatic medullary thyroid carcinoma.
    Ozkan ZG, Kuyumcu S, Uzum AK, Gecer MF, Ozel S, Aral F, Adalet I.
    Nucl Med Commun; 2015 Mar; 36(3):242-50. PubMed ID: 25369749
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.